Specifically, our analysis of patient specimens implied that overall survival was worse for those patients whose tumours are GRP78-negative/IGFBP-3-positive than for those with GRP78-negative/IGFBP-3 negative tumours. The gene discussed is IGFBP3; the disease is neoplasm.